Gene Query: OGDHL

Dataset Description Geneva Score
RNA-seq analysis of BAP1-depleted uveal melanoma cells 48.61
Genome-wide functional assessment of enhancer activities in the human genome 35.63
Effect of ER stress on MUC1 kidney disease patient derived cells and and treatment by BRD4780 34.13
Genome-wide identification of cancer-specific alternative splicing in circRNA 32.97
RNA-seq of HBV-infected Primary Human Hepatocytes treatment by Tazarotene 32.92
HNF1 regulates critical functions of the human epididymis epithelium. [RNA-Seq] 29.74
HNF1 regulates critical functions of the human epididymis epithelium. 29.74
Endometrial epithelial cell transcriptome response to co-culture with adipose stromal cells 26.68
Divergent expression and metabolic functions of human glucuronosyltransferases through alternative splicing 23.21
Gene expression profiles of isogenic single-cell derived clones of BRAF-mutated SK-MEL-5 melanoma cell lines 22.54
Transcriptomic and gene ontology profiling of the human corneal cell types 21.11
RNA helicase A is necessary for KIF1Bβ tumor suppression in neuroblastoma 20.31
Quantitative profiling of the UGT transcriptome in human drug metabolizing tissues [Total RNA] 18.89
Splicing function of mitotic regulators links R-loop mediated DNA damage to tumor cell killing 18.29
Massive parallel sequencing uncovers actionable FGFR2-PPHLN1 fusion and ARAF mutations in intrahepatic cholangiocarcinoma 18.05
Transcriptomics profiles of patient-matched normal kidney and ccRCC pairs 17.35
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia 17.33
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia [RNA-seq] 17.33
Episomal HBV persistence within transcribed host nuclear chromatin compartments involves HBx 16.72
Effect of 48h treatment with 100nM GSK2879552 on T-ALL cell lines HSB2 and RPMI8402 16.71
Dioxin and AHR impairs mesoderm gene expression and cardiac differentiation in human embryonic stem cells (RNA-Seq) 16.25
Dioxin and AHR impairs mesoderm gene expression and cardiac differentiation in human embryonic stem cells 16.25
Universal alternative splicing of noncoding exons 16.17
Dynamics of the human and viral m6A RNA methylomes during HIV-1 infection of T cells 16.16
Genome-wide analysis of YAP and TFCP2 occupancy and regulated expression in liver cancer cells 15.68
Genome-wide analysis of YAP and TFCP2 down-regulated genes in liver cancer cells 15.68
Gene expression analysis of human liver progenitor-like cells in culture 15.49
FOXP2's impact on the primate transcriptome 15.41
Human Hepatocytes with Drug Metabolic Function Induced from Fibroblasts by Lineage Reprogramming 13.82
Transcriptome analysis of human reninomas as an approach to understanding juxtaglomerular cell biology 13.76
Next Generation Sequencing of human SMA and healthy control Motor Neurons 13.34
Comprehensive evaluation of differential gene expression analysis methods for RNA-seq data 12.78
Over expression of Receptor Activity Modifying Protein 2 in HEK293T cells 12.71
Premature polyadenylation-mediated loss of stathmin-2 is a hallmark of TDP-43-dependent neurodegeneration 12.52
Gene expression profile difference among renal location in a stone former 12.33
Appropriately Differentiated ARPE-19 Cells Regain a Native Phenotype and Similar Gene Expression Profile 12.18
RNA sequencing reveals levamisole target genes PTPRZ1 and MDK and their links to interferon pathway in human podocytes 12.08
Effect of circPTPRM on the biological behaviors of hepatocellular carcinoma cells in vitro and its clinical significance. 12.08
Global epigenomic reconfiguration during mammalian brain development 12.07
Risk SNPs mediated promoter-enhancer switching promotes prostate cancer progression through lncRNA PCAT19 (RNA-seq data sets) 11.98
Risk SNPs mediated promoter-enhancer switching promotes prostate cancer progression through lncRNA PCAT19 11.98
Transcriptomic analysis of cultured corneal endothelial cells as a validation for their use in cell-replacement therapy 11.84
Transcriptional profile of CAOV2 primary and CAOV2 recurrent cells 11.73
Gene Expression Profiling of SPOP Knocked Down Cell 11.23
RNAseq data from SCCOHT1 and OVCAR8 ovarian cancer cells treated with BET inhibitors 11.17
Comparing oestrogen-responsive genes in endometrial and breast cancer cell lines 10.88
Chemical Modulation of Glycolysis Regulates the KEAP1-NRF2 Pathway Through a Metabolite-Induced Posttranslational Modification 10.83
Whole genome analysis of the methylome and hydroxymethylome in normal and malignant lung and liver 10.78
Whole genome analysis of the methylome and hydroxymethylome in normal and malignant lung and liver [RNA-Seq] 10.78
The multiple myeloma risk allele at 5q15 lowers ELL2 expression and increases ribosomal gene expression [ELL2 KO] 10.54
RNA-seq data from human lymphoma cell lines 10.5
ChIP-seq and RNA-seq from human lymphoma cell lines 10.5
UBE3A-mediated regulation of imprinted genes and epigenome-wide marks in human neurons 10.42
BioProject PRJNA381064: Convergent origination of a Drosophila-like dosage compensation mechanism in a reptile lineage (Gene expression profiling in several tetrapod species, bulk tissue RNA-seq) 10.22
The effect of insulin on mRNA transcription of human pluripotent stem cells 10.1
Novel kinase fusion oncogenes in post-Chernobyl radiation-induced pediatric thyroid cancers 9.86
ZNF131 suppresses centrosome fragmentation in Glioblastoma stem-like cells through regulation of HAUS5 9.76
mRNA and RNC-mRNA deep sequencing of three hepatocellular carcinoma cell lines 9.39
Comparative analysis of kidney organoid and adult human kidney single cell and single nucleus transcriptomes 9.27
Neuronal brain region-specific DNA methylation and chromatin accessibility are associated with neuropsychiatric trait heritability 9.14
Neuronal brain region-specific DNA methylation and chromatin accessibility are associated with neuropsychiatric trait heritability [RNA-Seq] 9.14
Ex vivo expanded human 3D Nephrospheres engraft long term and repair chronic renal injury in mice 8.94
High-depth RNA sequencing of isogenic wild-type, PIK3CA-WT/H1047R and PIK3CA-H1047R/H1047R human iPSCs 8.92
Analyses of a panel of transcripts and construction of RNA networks in hepatocellular carcinoma 8.85
The Glioma-Infiltrating T Cell Receptor Repertoire 8.69
Identification of long noncoding RNAs in T-ALL cell lines 8.66
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 [HOM] 8.65
The expression of genes encoding palmitoylated proteins in axonal and synaptic compartments is affected in CLN1/PPT1 transfected neuronal cells 8.55
Discovery and verification of liver cancer marker genes and variable scission based on second-generation sequencing data analysis 8.45
Low carbohydrate diet study for non-alcoholic fatty liver disease patients 8.32
Understanding the reproducibility and robustness of the kidney organoid differentiation protocol using RNA-seq 8.04
Elucidating the microRNA-203 specific biological processes in glioblastoma cells from comprehensive high-throughput RNA-sequencing transcriptome profiling 8.01
RNA-Seq expression profiling of hepatocellular carcinoma and adjacent non-tumor liver tissues 7.92
Paired Related Homeobox Protein 1 Regulates Quiescence in Human Oligodendrocyte Progenitors 7.75
The expression profiles of GBC liver metastasis 7.66
Transcriptome analysis of VCaP xenografts resistant to dual therapy with abiraterone and enzalutamide 7.64
RNA sequencing analysis of human podocytes reveals glucocorticoid regulated gene networks targeting non-immune pathways 7.59
Transcriptome profiling of HepG2 cells upon treatment of the menin-MLL inhibitor MI-503 or DMSO 7.58
RNA Missplicing in Fuchs Endothelial Corneal Dystrophy 7.53
Transcriptomic of MKD (MUC1 kidney disease) patient compares to normal derived kidney epithelial cells 7.51
Coordination of neuron production in mouse and human cerebral cortex by the homolog of Drosophila Mastermind protein 7.48
Analyzing the interactions of mRNAs, miRNAs, lncRNAs and circRNAs to predict competing endogenous RNA networks in glioblastoma 7.41
Modeling and characterization of the dynamic gene regulatory networks underlying cancer drug resistance based on time-course RNA-seq data 7.34
The ALK downregulated target gene HBP1 and repressor of MYCN activity as synergistic target for combined PI3K/HDAC inhibition [RNA-Seq] 7.31
The ALK downregulated target gene HBP1 and repressor of MYCN activity as synergistic target for combined PI3K/HDAC inhibition 7.31
circRNA-sequencing 7.29
Cooperation between TLX1 and the NUP214-ABL1/STAT5 signaling in T-cell acute lymphoblastic leukemia 7.28
Repurposing of promoters and enhancers during mammalian evolution 7.21
Heterozygous and homozygous knock-in of PIK3CA-H1047R into human iPSCs 6.78
Hepatic transcriptome of pediatric hepatoblastoma. 6.76
Integrating the Epigenome to Identify Novel Drivers of Hepatocellular Carcinoma 6.63
Integrative analysis of microRNAs and mRNAs in liver tissue and exosomes from blood of hepatitis C virus (HCV) related hepatocellular carcinoma (HCC) patient to identify biomarker and regulators of HCC [Total RNA-Seq] 6.58
Integrative analysis of microRNAs and mRNAs in liver tissue and exosomes from blood of hepatitis C virus (HCV) related hepatocellular carcinoma (HCC) patient to identify biomarker and regulators of HCC 6.58
Gene expression of collecting duct carcinoma of the kidney 6.57
Region-specific Innate Antiviral Responses of the Human Epididymis 6.54
An in vitro human liver model by iPSC-derived parenchymal and non-parenchymal cells 6.42
Genistein and bisphenol A exposure cause estrogen receptor 1 to bind thousands of binding sites in a cell type-specific manner 6.36
CENPA-Bound Genes and Transcriptional Profiling of CENPA-Depleted Prostate Cancer Cells 6.28
Transcriptional Profiling of CENPA-Depleted Prostate Cancer Cell Lines 6.28
Transcriptomes of iPSC-derived and post-mortum Hypothalamus Neurons from obese and control donors 6.28
Patient-iPSC-derived kidney organoids show functional validation of a ciliopathic renal phenotype 6.1
Disruption of Na+/H+ exchanger regulatory factor 2 scaffold suppresses colon cancer proliferation 6.0
Pervasive transcription read-through promotes aberrant expression of oncogenes and RNA chimeras in renal carcinoma 5.93
SMN deficiency in spinal muscular atrophy causes widespread intron retention and DNA damage 5.82
Transcriptome analysis of small molecule-mediated astrocyte-to-neuron reprogramming 5.79
Landscapes of gene translation in hepatocellular carcinoma tumors revealed by ribosome profiling 5.78
Effect of 48h treatment with 100nM GSK2879552 on T-ALL cell lines LOUCY and PEER 5.77
AR-independent prostate cancer is sustained through FGF signaling 5.74
RNA-Seq in two Ewing sarcoma cell lines: A673 and SKNMC 5.7
Human SETMAR is a DNA sequence-specific histone-methylase with a broad effect on the transcriptome 5.66
Chromatin remodeling mediated by ARID1A is indispensable for normal hematopoiesis in mice (human RNA-Seq) 5.6
RNA-seq analysis of the human fetal kidney. 5.49
Mutations in EBF3 disturb transcriptional profiles and cause intellectual disability, ataxia and facial dysmorphism 5.42
Expression profiling by high throughput sequencing of tumors derived from human prostate epithelial cells transformed with the oncogenes N-Myc and myrAKT1. 5.33
Global Transcriptional analysis of human spinal cord and neocortical neuroepithelial stem (NES) cells 5.23
lncRNA-PCAT1 knockdown effect on the gene expression of androgen independent LNCaP (LNCaP-AI) cell line 5.23
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L [RNA-Seq KO] 5.16
Transcriptome variation among human embryonic stem cell lines impacts on their differentiation 5.12
Multiple mechanisms disrupt let-7 miRNA biogenesis and function in neuroblastoma [longRNA] 5.11
Human iPSC derived glomeruli facilitate accurate modelling of podocytopathy 5.1
Epigenetic Inactivation of Cysteine Dioxygenase Type 1 Contributes to ROS-dependent Progression of Colorectal Cancer 5.03
TMED9-gated CNIH4 and TGFa signaling promotes pro-metastatic states in human primary colon cancer cells 4.93
Downregulation of DDX5/DDX17 and REST 4.91
IDH3a KO RNA-seq 4.84
An integrative network biology analysis identifies miR-508-3p as the determinant and a prognosis biomarker of the mesenchymal subtype ovarian cancer 4.77
SRSF2 mutations impair hematopoiesis and alter exon recognition 4.75
Gene expression profiling of iPSC-derived cardiomyocytes with BAG3 mutations 4.73
DNMT1-associated long non-coding RNA regulate global gene expression and DNA methylation in colon cancer 4.59
HSB-2 cells stably expressing LDB1 or mutant LDB1 proteins 4.55
RNA-Seq in PWS iPSC-derived neurons 4.5
Global transcriptome analysis in the MYCN-amplified neuroblastoma cell line IMR5-75 upon inducible MYCN-knockdown 4.49
Transcription-dependent control of stem cell self-renewal and differentiation by the splicing factor U2AF1 4.47
MYCL and EP400 are required for Max and MCPyV mediated gene activation 4.41
Multiple mechanisms disrupt let-7 miRNA biogenesis and function in neuroblastoma 4.38
JMJD3 facilitates C/EBPβ-centered transcriptional program to exert oncorepressor activity in AML 4.38
RNA-seq analysis of uveal melanoma cells treated with FR900359 4.38
Hyper-activation of HUSH complex function by Charcot-Marie-Tooth disease mutation in MORC2 4.36
CDK4/6 inhibitor resistance in prostate cancer 4.35
A damaged genome's transcriptional landscape through multilayered expression profiling around in situ-mapped DNA double-strand breaks 4.35
iPSC-Derived Cholangiocytes 4.3
Cystathionine-β-Synthase Promotes Colon Carcinogenesis 4.18
RNA-seq analysis of HT-29, MCF10A, and MDA-MB-436 cells 4.15
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L 4.12
High-throughput sequencing of the human hepatic progenitor cell niche in PSC and HCV. 4.09
Transcriptomic profiling discloses molecular and cellular events related to neuronal differentiation in SH-SY5Y cells 4.09
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma 4.08
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma (RNA-Seq) 4.08
Mapping cis-regulatory chromatin contacts in neural cells links neuropsychiatric disorder risk variants to target genes [RNA-Seq] 3.95
Mapping cis-regulatory chromatin contacts in neural cells links neuropsychiatric disorder risk variants to target genes 3.95
RNA-Seq identifies condition-specific biological signatures of ischemia-reperfusion injury in the human kidney 3.92
RNA-Seq profiling of iPSC-derived ventricular and atrial cardiomyocytes 3.9
Apatinib preferentially inhibits Gefitinib-resistant lung cancer cells by inducing cell cycle arrest and inhibiting VEGFR signaling pathway 3.85
Leucegene: ALL sequencing 3.84
Growth factor-free, chemically-defined culture system for expansion and derivation of human pluripotent stem cells 3.81
Human embryonic stem cells in E8 and AKIT culture medium 3.81
Development of an In Vitro Human Liver System for Interrogating Non-Alcoholic Steatohepatitis 3.7
RNA expression analysis of neuroblastoma cell lines treated with epigenetic drugs 3.69
RNA-Seq profiling of day 7 and day 18 kidney organoids differentiated in two batches 3.68
Thymine DNA Glycosylase as a novel target for melanoma: effect of TDG silencing on gene expression in SK-mel-28 melanoma cells 3.66
Human TFIIH kinase CDK7 regulates transcription-associated epigenetic modification 3.64
Transcriptome analysis in HT29 and SW480 cells depleted of Prdx2 3.64
RNA-seq analysis of the role of HBO1 (KAT7/MYST2) in the ovarian cancer cell line UWB1.289. 3.59
Expression profiles of the four human major ectodermal lineages 3.58
Arginine methylation controls cell proliferation by integrating E2F activity with the splicing machinery 3.57
Arginine methylation controls cell proliferation by integrating E2F activity with the splicing machinery (RNA-seq data set) 3.57
yylncT acts as a gatekeeper of the mesodermal transcriptional program by local modulation of DNMT3B [human_2] 3.56
LncRNA NMR knockdown and overexpression in esophageal squamous cell carcinoma cell lines 3.55
Mechanosensitive ion channel regulates tissue stiffening to promote glioma aggression 3.53
Modulation of nonsense-mediated decay by rapamycin 3.52
An epigenetic mark of polycomb response elements implemented by Trx/MLL/COMPASS 3.49
Gene expression profile in endometrial organoids cultured in normal follicular phase vs PCOS-like hormone profile 3.49
Differetially expressed genes after hTR overexpression in U2OS cells 3.44
Differential RNA-seq analysis comparing APC-defective and APC-restored SW480 colorectal cancer cells 3.43
SMUG1 promotes telomere maintenance through telomerase RNA end-processing 3.41
Genes encoding cognate receptors for IRI-related recipient cytokines are expressed in donor livers 3.37
Defining a microRNA-mRNA targetome for calcineurin inhibitor induced nephrotoxicity 3.34
GATA3 enhances the neurogenic potential of primary human astrocytes after traumatic injury [exp2] 3.31
Molecular analysis of renal cell carcinoma with unclassfied histology 3.27
Molecular analysis of renal cell carcinoma with unclassfied histology [gene expression] 3.27
RNA splicing alteration on glioblastoma and normal neural stem cells 3.27
High-Throughput Kinetic Analysis of Fractional Killing 3.23
Characterizing the contrasting roles of JMJD3 and UTX histone demethylases in T cell acute lymphoblastic leukemia [short_hairpins_RNA-seq] 3.21
Next generation sequencing analysis of transcriptomes at different timepoints after chlorprothixene treatment in NB4 and Kasumi-1 cells 3.18
HuR controls apoptosis and activation response without effects on cytokine 3′ UTRs 3.15
Tamoxifen Resistance in Breast Cancer is Regulated by the EZH2-ERa-GREB1 Transcriptional Axis 3.15
Ro60-knockout cells 3.14
ELF1 expression in prostate cells reduces oncogenic ETS functions and promotes senescence and sensitivity to chemotherapy through distinct gene expression programs 3.13
ELF1 expression in prostate cells reduces oncogenic ETS functions and promotes senescence and sensitivity to chemotherapy through distinct gene expression programs [RNA-seq] 3.13
RNA sequencing analysis of human embryonic stem cells and axial progenitors 3.12
Defective transcription elongation in a subset of cancers confers immunotherapy resistance 3.11
POLR3G Dependent PolyA+ and smallRNA Transcriptomes in Human Pluripotent Stem Cells 3.08
Whole transcriptome RNA sequencing of human cells after HCV infection (ML-1 thyroid cell line, primary thyrocytes and Huh7.5 hepatocyte cell line) 3.04
Differential roles of human PUS10 in miRNA processing and tRNA pseudouridylation 3.01
Circular RNAs in the mammalian brain are highly abundant, conserved, and dynamically expressed 3.0
A SRp55-regulated alternative splicing network controls pancreatic beta cell survival and function 2.99
The landscape of alternative splicing in aggressive prostate cancers 2.99
Human iPSC-derived glomeruli provide an advanced model to interrogate podocyte biology and accurately recapitulate podocytopathy 2.97
RNA-seq analysis of AML cells in response to ASLAN003 2.96
RNA sequencing for human induced pluripotent stem cell cardiomyocyte differentiation 2.94
Quantitative Analysis of PPARD Transcriptomes in Colon Cancer Cells by Next Generation Sequencing (NGS) 2.93
Human Cactin interacts with DHX8 and SRRM2 to assure efficient pre-mRNA splicing and sister chromatid cohesion. 2.93
Gene Expression Profiling of WT and KDM3A Knocked out Cell 2.86
Genome-wide maps of chromatin state and Gene Expression Profiling in HCT116 cells 2.86
mRNA-Seq profiling of human developing kidney 2.84
Real-time observation of light-controlled transcription in living cells 2.82
Lineage specific differentiation is influenced by state of human pluripotency [RNA-seq] 2.8
Lineage specific differentiation is influenced by state of human pluripotency 2.8
Effect of BET bromodomain inhibition with JQ1 in stressed human derived iPS cardiomyocytes 2.79
BET bromodomain inhibition 2.79
Expression charcaterization of an internal protocol developed to differentiate RPE cells 2.68
The hematopoietic master transcription factor PU.1 requires its interaction with the SWI/SNF remodeler to access chromatin de novo 2.66
The hematopoietic master transcription factor PU.1 requires its interaction with the SWI/SNF remodeler to access chromatin de novo [RNA-seq] 2.66
Discovery of a Drug Candidate for GLIS3-Associated Diabetes 2.65
Gene expression profiling of papillary thyroid cancer from central and invasive regions 2.63
Derivation of kidney organoids from human pluripotent stem cells [RNA-Seq: Data Set 2] 2.61
Survival of pancreatic cancer cells lacking KRAS function 2.61
Differential expression of human parthenogenic stem cells, neural stem cells and DA progenitors. 2.61
Analysis of transcrptomes of Danon patient derived hiPSC-cardiomyocytes by RNA-deep Sequencing 2.59
Transcriptome sequencing identify a recurrent CRYL1-IFT88 chimeric transcript in hepatocellular carcinoma 2.58
A genomic study of the contribution of DNA methylation to regulatory evolution in primates 2.57
Endometrial transcriptome and PGR cistrome in cycling fertile women 2.56
Endometrial transcriptome and PGR cistrome in cycling fertile women [RNA-seq] 2.56
H3.3K27M cooperates with p53 loss and Pdgfra gain in mouse embryonic neural progenitor cells to induce invasive high-grade gliomas 2.56
H3.3K27M cooperates with p53 loss and Pdgfra gain in mouse embryonic neural progenitor cells to induce invasive high-grade gliomas [Human RNA-Seq] 2.56
Transcriptional profiling of healthy, eutopic and ectopic endometrial organoids 2.55
LSD1 mediates AKT activity in PIK3CA mutant colorectal cancer [RNA-Seq] 2.55
LSD1 mediates AKT activity in PIK3CA mutant colorectal cancer 2.55
hTERT promotes cell adhesion and migration independent of telomerase activity 2.54
Loss of CHD1 facilitates oncogenic hijacking of AR during cancer progression [RNA-seq] 2.52
Loss of CHD1 facilitates oncogenic hijacking of AR during cancer progression 2.52
The age and genomic integrity of neurons after cortical stroke in humans 2.51
Comparison between THP-1 cells obtained from either ATCC or DSMZ biorepository 2.5
RNA-seq of exosomes identifies lncRNA profiles that distinguish early-stage esophageal squamous cell carcinoma (ESCC) from non-malignant esophagitis 2.5
Genomic basis for clinical response to histone deacetylase inhibition in advanced urothelial carcinoma 2.49
Identification of novel recurrent ETV6-IGH fusions in primary central nervous system lymphoma using high throughput RNA sequencing 2.49
FUS mutant human motoneurons transcriptome analysis reveals altered pathways and impairment of microRNA function 2.49
Discovery of cis-spliced chimeric RNAs between adjacent genes in human prostate cells 2.47
RNA-Sequencing experiment for effects of PKF115-584 treatment on four T-ALL cell lines (RPMI8402, HPB-ALL, Jurkat, CCRF-CEM). 2.44
ELF4 is a target of miR-124 and promotes neuroblastoma proliferation and undifferentiated state 2.44
Biological effect of chronic mistranslation in mammalian cells 2.4
RNA-seq of human aneuploid cell lines with Trisomy 21 2.4
Analysis of human, chimpanzee, macaque and mouse tissue transcriptomes using Next Generation Sequencing 2.4
Mucosal Profiling of Pediatric-Onset Colitis and IBD Reveals Common Pathogenics and Therapeutic Pathways 2.39
Super-enhancer-driven CCAT1 is co-activated by SOX2 and TP63 and promotes squamous cancer from esophagus, head and neck and lung 2.38
Super-enhancer-driven CCAT1 is co-activated by SOX2 and TP63 and promotes squamous cancer from esophagus, head and neck and lung [RNA-seq] 2.38
Global Regulation of Alternative Internal Exon Usage by mRNA 3' End Formation Factors [RNA-Seq] 2.33
Global Promotion of Alternative Internal Exon Usage by mRNA 3' End Formation Factors 2.33
Single-cell RNA-Seq Investigation of Foveal and Peripheral Expression in the Human Retina 2.32
Inducible three-factor direct reprogramming to nephron progenitors using piggyBac transposons 2.32
Increased Neanderthal ancestry in genomic regions associated with lipid catabolism in contemporary Europeans 2.31
FOXP1 orchestration of ASD-relevant signaling pathways. 2.3
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation [RNA-Seq SS] 2.28
BRD9 defines a novel SWI/SNF sub-complex and constitutes a specific vulnerability in malignant rhabdoid tumors 2.25
ARID1A and ARID1B loss in HCT116 cells 2.24
RNA-seq of naive and primed ES cells 2.24
Transcriptional Targeting Of Oncogene Addiction In Medullary Thyroid Cancer [RNA-Seq] 2.24
Transcriptional Targeting Of Oncogene Addiction In Medullary Thyroid Cancer 2.24
EP400 is required for Max and MCPyV mediated gene activation 2.21
Transcriptome-wide identification of CELF2 functional targets in T cells 2.21
Leucegene: AML sequencing (part 6) 2.21
ETV4 is necessary for estrogen signaling and growth in endometrial cancer cells [RNA-seq] 2.2
ETV4 is necessary for estrogen signaling and growth in endometrial cancer cells 2.2
Recurrent somatic mutations in POLR2A define a distinct subset of meningiomas [RNA-seq] 2.2
Recurrent somatic mutations in POLR2A define a distinct subset of meningiomas 2.2
RNA-Seq and ATAC-Seq in SMARCD2 k/d NB4 cells with/without ATRA differentiation 2.2
RNA-Seq in SMARCD2 k/d NB4 cells with/without ATRA differentiation 2.2
Transcriptome analysis of kidney organoids 2.19
Mutant KRAS/BRAF Reprograms the Enhancer Landscape via GATA1 to Drive Chemoresistance 2.19
Comparative principles of DNA methylation reprogramming during human and mouse in vitro primordial germ cell specification [Mouse and Human RNA-seq and BS-seq] 2.17
Comparative principles of DNA methylation reprogramming during human and mouse in vitro primordial germ cell specification 2.17
AhR activity directs BRAF inhibitors resistance in metastastic melanoma 2.17
Loss of EGFR-DDEF1 signaling in metastatic and unresectable hepatoblastoma 2.15
Transcriptomic analysis of the effect of trastuzumab in human iPSC-CMs 2.15
Genomic Reorganization of Lamin-Associated Domains in Cardiac Myocytes is Associated with Differential Gene Expression and DNA Methylation in Human Dilated Cardiomyopathy [RNA-Seq] 2.15
Genomic Reorganization of Lamin-Associated Domains in Cardiac Myocytes is Associated with Differential Gene Expression and DNA Methylation in Human Dilated Cardiomyopathy 2.15
Zone dependent distinctive gene expression profile of the normal human liver tissue 2.14
Global gene expression profiles of cardiac progenitors differentiated from human pluripotent stem cells in 3D culture under simulated microgravity 2.14
CRISPR activation of long non-coding RNAs transiently expressed during cortical neuron differentiation associated with Field, et al, Stem Cell Reports 2018 2.13
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability 2.12
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability (22RV1 RNA-seq) 2.12
Profiling gene expression changes in primary ovarian tumors compared to matched normal fallopian tubes 2.12
Treatment Paradigms for Retinal and Macular Diseases Using 3-D Retina Cultures Derived From Human Reporter Pluripotent Stem Cell Lines 2.12
A Werner syndrome stem cell model unveils heterochromatin alterations as a driver of human aging 2.12
Profiling gene expression changes in ovarian cancer cells seeded on 3D organotypic culture of omentum 2.11
Safeguarding nucleolar homeostasis by CBX4 alleviates senescence and osteoarthritis 2.1
Transcriptome analysis reveals malignant and hypoxic signature of glioblastoma 2.1
Quantitative Analysis of negative control and overexpression-TRIB1 in PC3 and DU145 Transcriptomes 2.1
GLIS3 Transcriptionally Activates WNT Genes to Promote Differentiation of Human Embryonic Stem Cells to Posterior Neural Progenitors 2.1
Somatic cell fusions reveal extensive heterogeneity in basal-like breast cancer [RNA-Seq] 2.09
Somatic cell fusions reveal extensive heterogeneity in basal-like breast cancer 2.09
Transcriptomes change differerntly in differernt cancer cells upon EPZ-6438 treatment 2.09
Transcription factors OVOL1 and OVOL2 induce the mesenchymal to epithelial transition in human cancer 2.09
The NORAD lncRNA assembles a topoisomerase complex critical for genome stability [RNA-seq] 2.09
The NORAD lncRNA assembles a topoisomerase complex critical for genome stability 2.09
Acquired resistance to MEK-CDK4/6 inhibitor combinations in cutaneous melanoma 2.08
A Primate lncRNA Mediates Notch Signaling During Neuronal Development by Sequestering miRNA [SHSY5Y cells] 2.07
The role of TFEB in retinoid induced differentiation of NB4 APL leukemic cells (shTFEB) 2.07
Gene expression analysis of immortalized human liver progenitor-like cells in culture 2.07
Maturing an Enteric Nervous System in Human Intestinal Organoid-derived Tissue-Engineered Small Intestine 2.04
Gene expression analysis of human haploid cells (HAP1) depleted of SMARCB1 and SMARCA4 2.02
LMO1 Synergizes with MYCN to Promotes Neuroblastoma Initiation and Metastasis 2.02
The Polycomb protein BMI1 induces an invasive gene expression signature in melanoma that promotes metastasis and chemoresistance. 2.01
Dynamic developmental signaling logic underlying lineage bifurcations during human endoderm induction and patterning from pluripotent stem cells [Endoderm RNA-seq and ChIP-seq data sets] 2.01
Dynamic developmental signaling logic underlying lineage bifurcations during human endoderm induction and patterning from pluripotent stem cells 2.01
Total RNAseq of human putamen and caudate nucleus tissues in healthy control and Bipolar Disorder individuals 2.01
Receptor tyrosine kinase signaling promotes post-embryonic morphogenesis and survival of glia and neural progenitor cells 1.98
Gene expression changes upon drug withdrawal (Mel888 cell line) 1.97
Comprehensive analysis of Long non-coding RNA expression in dorsal root ganglion reveals cell type specificity and dysregulation following nerve injury [human iPS] 1.95
Comprehensive analysis of Long non-coding RNA expression in dorsal root ganglion reveals cell type specificity and dysregulation following nerve injury 1.95
The long non-coding RNA MALAT1 contributes to the pathogenesis of multiple sclerosis through alternative splicing and backsplicing regulation 1.95
Intrinsic histone acetyltransferase activity of BRD4 is responsible for nucleosome eviction and transcriptional activation 1.94
RNA-seq analysis of SKMEL28 melanoma cells following DIRC3 and IGFBP5 ASO knockdown 1.93
Effect of selective glucocorticoid receptor modulation (SGRM) on gene expression in human prostate cancer cell lines 1.91
Expansion, in vivo-ex vivo cycling and genetic manipulation of primary human hepatocytes 1.89
ICF-specific DNMT3B dysfunction interferes with intragenic regulation of mRNA transcription and alternative splicing (RNA-seq) 1.88
ICF-specific DNMT3B dysfunction interferes with intragenic regulation of mRNA transcription and alternative splicing 1.88
Tyrosine Kinase Inhibitor Cardiotoxicity 1.87
High-Throughput Screening of Human Induced Pluripotent Stem Cell Cardiomyocytes Predicts Tyrosine Kinase Inhibitor Cardiotoxicity 1.87
Small molecule-mediated reprogramming of human hepatocytes into bipotent progenitor cells 1.87
Non-coding and coding transcriptional profiles are significantly altered in pediatric Retinoblastoma tumors 1.86
Expression profile of HNF1A knockdown and overexpression in 22RV1 and LNCaP cells respectively 1.86
Small-molecule-based Human Genome G4 Profiling Reveals Potential Gene Regulation Activity 1.86
High-efficiency RNA-based reprogramming of human primary fibroblasts 1.85
Maintaining iron homeostasis is the key role of lysosomal acidity for cell proliferation 1.83
Integrated Multi-omic Analysis of Esthesioneuroblastomas Identifies Two Subgroups Linked to Cell Ontogeny 1.82
Alagille_Nodder 1.81
RNA Seq of Alagille liver biopsies 1.81
Transcriptome analyses of human pancreatic islets and pseudoislets 1.79
Small molecule targets TMED9, promotes lysosomal degradation to reverse proteinopathy 1.79
Kidney compartment specific eQTL studies highlight causal genes and pathways for renal disease development 1.78
The global transcriptome analysis in the time course of hESC-derived cardiac differentiation 1.78
Comparing gene expression in iPSC derived RPE from control and AMD donors 1.77
Poly(ADP-ribose) polymerase 1 is necessary for coactivating hypoxia-inducible factor-1-dependent gene expression by Epstein-Barr virus latent membrane protein 1 1.77
Neuronal deletion of Gtf2i, associated with Williams syndrome, causes behavioural and myelin alterations rescuable by a remyelinating drug [human] 1.75
Neuronal deletion of Gtf2i, associated with Williams syndrome, causes behavioural and myelin alterations rescuable by a remyelinating drug 1.75
LncPRESS1 is a p53-regulated lncRNA that safeguards pluripotency by disrupting SIRT6 mediated de-acetylation of histone H3K56 1.74
Role of FGFR1 in neuronal devlopment 1.74
Pancreatic Beta Cell Enhancers Regulate Rhythmic Transcription of Exocyst Triggering and Diabetes 1.73
Genome-wide Circadian Control of Transcription at Active Enhancers Regulates Insulin Secretion and Diabetes Risk 1.73
The antineoplastic drug, trastuzumab, dysregulates metabolism in iPSC derived cardiomyocytes. 1.72
The ribosomal prolyl-hydroxylase OGFOD1 decreases during cardiac differentiation, modulates translation and spliceosomal processes 1.71
Human Induced Pluripotent Stem Cells Recapitulate Breast Cancer Patients’ Predilection to Doxorubicin-Induced Cardiotoxicity 1.71
Systematic analysis of gene expression profiles controlled by hnRNP Q and hnRNP R, two closely related human heterogeneous nuclear ribonucleoproteins. 1.71
RNA-Seq of Breast and Ovarian Cancer Cell Lines 1.66
Evaluating and comparing the Transcriptome of (human) Hek 293 based cells, expressing either CHD3 or CHD4 1.66
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability (LNCaP RNA-seq) 1.64
Urinary sediment transcriptomic and longitudinal data to investigate renal function decline in type 1 diabetes 1.64
Dexamethasone inhibits respiratory syncytial virus-driven mucus production while increasing viral replication without altering antiviral interferon signaling 1.62
NOTCH signaling is activated in and contributes to resistance in enzalutamide-resistant prostate cancer cells 1.62
p53 activity results in DNA replication fork processivity 1.62
Molecular Criteria for Defining the Naive Human Pluripotent State 1.62
The regulation of ferroptosis by TAZ in epithelial ovarian cancer 1.62
Differentiation enhances Zika virus infection in neuronal brain cells 1.61
RNA-seq analysis of control and Myc-induced U2OS cells 1.59
Cis-SAGe fusion RNAs in transcription splicing factors knocking-down 293T cells 1.58
Transcriptome profiling of a mouse model of alveolar soft part sarcoma 1.58
A cell cycle-based functional screen to identify lncRNA-based cancer biomarkers 1.57
Epigenetic siRNA and chemical screens identify SETD8 inhibition as a new therapeutic strategy of p53 reactivation in high-risk Neuroblastoma. 1.56
Transcriptomic analysis of human neural progenitor cells differentiation into astrocytes 1.54
Virus-like vesicles of Kaposi’s Sarcoma-Associated Herpesvirus activate lytic replication through triggering differentiation signaling 1.53
Identification of a unique subtype of lung squamous cell carcinoma defined by SOX2 and a neural differentiation factor BRN2 1.53
Identification of a unique subtype of lung squamous cell carcinoma defined by SOX2 and a neural differentiation factor BRN2 [RNA-seq] 1.53
DGCR8 acts as a novel adaptor for the exosome complex to degrade double-stranded structured RNAs 1.52
Evaluating pre-clinical models for studying NASH driven HCC. 1.52
Global gene expression profiles of cardiomyocytes differentiated from human pluripotent stem cells (hiPSC-CMs) in 3D culture exposed to ethanol 1.52
Genome wide transcript and miRNAanalysis of invitro and in-vivo generated human cardiac samples 1.52
The lipodystrophic hotspot lamin A p.R482W mutation deregulates the mesodermal inducer T/Brachyury and early vascular differentiation gene networks 1.51
Stranded RNA-seq were performed on total RNA following ribosomal RNAs depletion (Ribo-zero removal kit, illumina) for 3 brain , 8 IDHwt and 5 IDHmut glioma samples. 1.5
Lipid catabolism inhibition sensitizes prostate cancer cells to antiandrogen blockade 1.49
Development of a selective CDK9 degrader from a multi-targeted CDK inhibitor 1.49
Development of a selective CDK9 degrader from a multi-targeted CDK inhibitor [RNA-seq] 1.49
Epigenomic plasticity enables human pancreatic alpha to beta cell reprogramming 1.49
Integrative analysis identifies lincRNAs up- and downstream of neuroblastoma driver genes (ALK) 1.46
RNAseq in Alzheimer's Disease patients 1.46
Loss of the Chr16p11.2 candidate gene QPRT leads to aberrant neuronal differentiation 1.45
Discovering human diabetes-risk gene function with genetics and physiological assays 1.44
Necroptosis inhibition protects from dopaminergic neuronal cell death in OPA1 mutant Parkinson’s disease patient neurons and MPTP treated mice 1.43
Generation, transcriptome profiling, and functional validation of cone-enriched human retinal organoids 1.41
Controlling for gene expression changes in transcription factor protein networks. 1.39
An intramolecular salt bridge linking TDP43’s RNA recognition motifs dictates RNA binding, protein stability and TDP43-dependent neurodegeneration 1.36
Genome-wide Dose-dependent Inhibition of Histone Deacetylases Reveals Their Roles in Enhancer Remodeling and Suppression of Oncogenic Super-enhancers 1.34
RNA-sequencing analysis of human fibrolamellar hepatocellular carcinoma and 4 maturational stages of the human hepatobiliary system 1.33
CDK4/6 inhibitors target SMARCA4-determined cyclin D1 deficiency in hypercalcemic small cell carcinoma of the ovary (I) 1.33
A specific missense mutation in GTF2I occurs at high frequency in thymic epithelial tumors 1.3
Global transcriptional analysis of human extended pluripotent stem cells, human primed pluripotent stem cells, mouse extended pluripotent stem cells, and mouse embryonic stem cells by RNA-seq 1.28
Global transcriptional analysis and genome-wide analysis of chromatin state in extended pluripotent stem cells, primed pluripotent stem cells, and naïve pluripotent stem cells 1.28
Differentially Expressed Genes for Atrial Fibrillation Identified using RNA Sequencing from Paired Human Left and Right Atrial Appendages. 1.18
FUS KO mRNA sequencing and anti-FUS RNA immunoprecipitation sequencing 1.15
MYT1 attenuates neuroblastoma cell differentiation by inhibiting retinoic acid signaling pathway 1.13
ENCODE Cold Spring Harbor Labs Long RNA-seq 1.1
Genome-wide RNA-sequencing of human islets 48 hour after transduction with adenoviruses expressing either GFP (control), or histone chaperone ASF1B. 1.08
Gene Expression Profile of human hepatocellular carcinoma by RNA sequencing 1.06
RNA-Seq in human T-cell lymphoblastic lymphoma samples and control thymuses 1.04
Human T-cell lymphoblastic lymphoma samples and control thymuses 1.04
Huntingtin aggregation impairs autophagy leading to Argonaute-2 accumulation and global microRNA dysregulation 1.02
RNA-sequencing WT vs SOCS3 knockout Glioblastoma stem-cells 1.01
Regulation of DNA methylation landscape in human somatic cell reprogramming by miR-29 family 1.0
Regulation of DNA methylation landscape in human somatic cell reprogramming by miR-29 family (RNA-seq) 1.0
Potent and targeted activation of HIV-1 using the CRISPR/Cas9 activator Complex 1.0
Genome wide association study of bone size yields eleven loci that also affect height, bone density, osteoarthritis and fractures 0.99
Gene expression analysis of human hepatocellular cancers 0.99
RNA-Sequencing shows novel transcriptomic signatures in failing and non-failing human heart 0.98
Functional Haploid Human Oocytes Generated from Polar Body Genomes 0.94
Functional Haploid Human Oocytes Generated from Polar Body Genomes (RNA-Seq) 0.94
RNA sequencing quantitative analysis of RNA editing levels in ADAR1, ADAR2, AIMP2 overexpression and wild type HEK293 cells 0.94
Identification of differential expressed genes of JQ1 or JQ1+Bortezomib in colorectal cancer cells 0.93
RNA-seq of naive and primed ES cells (NHSM) 0.92
Major hnRNP proteins act as general TDP-43 functional modifiers both in Drosophila and human neuronal cells. 0.88
FGF2 regulation of gene expression in stable inducible Neurons 0.88
Expression profile of GIST48 cells with siETV1 or siFOXF1 knockdown 0.86
FOXF1 defines the core-regulatory circuitry in gastrointestinal stromal tumor (GIST) 0.86
Identification and mitigation of pervasive off-target activity in CRISPR-Cas9 screens for essential non-coding elements 0.85
Gene expression patterns define the hepatocyte-like cells derived by different strategies [RNA-seq] 0.82
Gene expression patterns define the hepatocyte-like cells derived by different strategies 0.82
Generation of low passage high grade serous ovarian cancer cell lines from primary tumors 0.82
Hepatocyte maturation 0.79
Inactivation of CFTR by CRISPR/Cas9 alters transcriptional regulation of inflammatory pathways and other networks 0.78
Genomic location of PRMT6-dependent H3R2 methylation is decisive for the transcriptional outcome of associated genes 0.78
Transcriptome analysis of PRMT6 knock-out in NT2/D1 cells 0.78
Deep sequencing of transcript levels in pluripotent stem cells and their differentiated derivatives in all three germ layers 0.78
RNA-Seq comparative analysis of human neuroblastoma cells before and after their confrontation to the embryonic microenvironment 0.78
In vivo generation of post-infarct human cardiac muscle by laminin-promoted cardiovascular progenitors [LN-521 or LN-521+LN-221] 0.76
Critical role of transient activation of human endogenous retroviruses during reprogramming toward pluripotency 0.76
Critical role of transient activation of human endogenous retroviruses during reprogramming toward pluripotency (RNA-Seq) 0.76
Genome-wide search for differentially expressed RNAs responsible for the effects induced by Ebola virus replication and transcription 0.74
Cerebral Organoids Recapitulate Epigenomic Signatures of the Human Fetal Brain 0.73
TALEN-based knockout of mir-141 and mir-200c in SK-BR-3 cells 0.72
Genome-wide transcriptome analysis of NIPBL iPSC and commited cardiomyoctes 0.71
Post-transcriptional remodelling is temporally deregulated during motor neurogenesis in human ALS models 0.71
Early transcriptome profiling of microRNA-mediated neuronal reprogramming [RNA-seq timecourse] 0.67
Defective transcription elongation in a subset of cancers confers immunotherapy resistance (BGI12 RNA-Seq) 0.65
Gene expression regulated by CSA and CSB in neuroblastoma cell line 0.62
Estrogen-independent molecular actions of mutant estrogen receptor alpha in endometrial cancer 0.61
Estrogen-independent molecular actions of mutant estrogen receptor alpha in endometrial cancer [RNA-seq] 0.61
RNA sequencing of human pancreatic cancer cell lines 0.61
Multiple sclerosis and EAE 0.59
Human optic chiasm from healthy controls and multiple sclerosis patients 0.59
Generating Patterned Kidney Organoids for Studying Development and Diseases [bulk RNA-Seq] 0.53
Human islets of varying quality: the good, the (not so) bad and the ugly 0.53
Characterizing the Chemoresistant Ovarian Cancer Population using the Heterogeneous PDX 0.52
Human ES Cell-derived Hepatoblasts are an Optimal Lineage Stage for HCV Infection 0.52
RNAseq analysis of ruxolitinib treated breast cancers 0.51
Preliminary Report of Transplantation of Human Fetal Retinal Pigment Epithelial Cells on Age-related Macular Degeneration Patients 0.48
Transcriptome sequencing of a large human family identifies the impact of rare non-coding variants 0.48
Expression profiles of restoration of BAP1 in a BAP1 deficient cell line 0.47
Transcriptome analysis of BAP1 knockout and restoration 0.47
Transcriptomics profiling of Alzheimer’s disease reveal novel molecular targets 0.45
Altered expression of signaling pathways regulating neuronal excitability in hippocampal tissue of temporal lobe epilepsy patients with low and high seizure frequency 0.44
Next generation sequencing of advanced non-castrate prostate cancer treated with docetaxel chemotherapy 0.44
Integrated multi-omics approach reveals a role of ALDH1A1 in lipid metabolism in human colon cancer cells 0.43
Image based identification and targeting of cancer stem cells in pancreatic adenocarcinoma (PDAC) 0.41
single cell RNA-seq from Purkinje cell (ENCSR888LYA) 0.41
Oncogenic roles of ARID5B in T-ALL 0.35
RNA-seq analysis in knockdown Jurkat samples for each factor of TAL1 complex 0.35
Integration of ATAC-seq and RNA-seq Identifies Human Alpha Cell and Beta Cell Signature Genes 0.33
Microenvironmental-derived Regulation of HIF-Signaling Drives Transcriptional Heterogeneity in Glioblastoma Multiforme 0.32
Whole transcriptome sequencing of the human thyroid primary cells with knock-down of the NRG1 gene 0.32
Identification of expressed and conserved human non-coding RNAs 0.31
Disease-associated mutation in SRSF2 misregulates splicing by altering RNA binding affinities 0.3
Epigenomic conservation of transposable element silencing [RNA-seq] 0.29
Epigenomic conservation of transposable element silencing 0.29
A Stable Transcription Factor Complex Nucleated by Dimeric AML1-ETO Controls Leukaemogenesis 0.28
Gene expression and chromatin organization changes in lamin A/C haploinsufficient human induced pluripotent stem cell-derived cardiomyocytes [RNA-seq] 0.28
Gene expression and chromatin organization changes in lamin A/C haploinsufficient human induced pluripotent stem cell-derived cardiomyocytes 0.28
CDK12 regulates alternative last exon mRNA splicing and promotes invasion of a breast cancer cell line 0.28
Effect of ILF3 depletion in HeLa cells on RNA steady state levels 0.27
Next Generation Sequencing Quantitative Analysis of Wild Type and AML1-ETO Related Fusion Circular RNA (F-CircAE) Knockdown Kasumi-1 Cells Transcriptomes 0.25
Network-based, cross-cohort discovery of transcriptional mechanisms presiding over maintenance of high-risk neuroblastoma subtype state 0.25
The multiple myeloma risk allele at 5q15 lowers ELL2 expression and increases ribosomal gene expression [ELL2 rescue] 0.24
Transcriptome-wide discovery of microRNA binding sites in human brain by Ago2 HITS-CLIP [Ago2-miRNA-target mRNA complexes] 0.23
Dynamic reorganization of nuclear architecture during human cardiogenesis 0.23
Dynamic reorganization of nuclear architecture during human cardiogenesis [RNA-seq] 0.23
Transcriptome Analysis Reveals Distinct Responses to Physiologic versus Toxic Manganese Exposure in Human Neuroblastoma Cells 0.21
Unbiased evaluation of cell-free amniotic fluid transcriptome of term and preterm infants to detect fetal maturity 0.19
RNA profiling Analysis of the Serum Exosomes Derived from Active and Latent M.tuberculosis infectious Patients 0.19
ARID1A and ARID1B loss in HCT116 and TOV21G cells 0.19
CRISPR/Cas9 Screens Reveal Epstein-Barr virus Synthetic Lethal Targets 0.18
PT2385 HIF2A inhibitor treatment of patient derived orthotopic xenograft neuroblastoma cells in the presence or absence of hypoxia 0.17
TrapSeq: An RNA Sequencing-based pipeline for the identification of genetrap insertions in mammalian cells 0.17
Transposon-based construction of strand-specific RNA-seq libraries 0.16
Effect of SF3B1 suppression in cancer cells with different SF3B1 copy-number levels 0.16
Targeted reactivation of FMR1 transcription in FXS embryonic stem cells 0.14
Next Generation Sequencing Facilitates Comparisons of Control and Schizophrenia-Patient derived hiPSC-derived neurons 0.13
Gene expression profiles of active and restricted R/G-HIV+ primary human fetal astrocytes 0.12
Transcriptome-wide discovery of microRNA binding sites in human brain by Ago2 HITS-CLIP 0.11
Transcriptional regulation in pluripotent stem cells by Methyl CpG binding protein 2 (MeCP2) 0.1
An integrative analysis of non-coding regulatory DNA variations associated with autism 0.1
Transcriptome data of temporal and cingulate cortex in the Rett syndrome brain 0.06
Gastrointestinal Stromal Tumor Enhancers Support a Transcription Factor Network Predictive of Clinical Outcome 0.05
Gastrointestinal Stromal Tumor Enhancers Support a Transcription Factor Network Predictive of Clinical Outcome 0.05
RNA-Seq of the corpus callosum from 12 individuals 0.05
Transcriptome analysis of SH-SY5Y cells after knockdown of circSLC45A4 0.05
RNA Sequencing of Human iPS derived Cardiomyocytes 0.05
Comparative transcriptome analysis reveals that ECM-Receptor Interaction contributes to the venous metastases of hepatocellular carcinoma 0.03
Screening in Human Cardiac Organoids Identifies a Requirement for the Mevalonate Pathway in Cardiomyocyte Proliferation 0.03
A Non-Canonical Nuclear Activity Triggered by Small RNAs and Argonaute Proteins in Human Cells 0.03
RNA expression profiles comparing primary and omental ovarian carcinoma samples 0.02
The SS18-SSX fusion oncoprotein hijacks BAF complex targeting and function to drive synovial sarcoma [RNA-Seq Tumor] 0.02
Expression data for hiPSC-derived RPE treated with 10mM Nicotinamide or vehicle 0.01
RNAseq of CCRF-CEM, a T-cell acute lymphoblastic leukemia cell line, after knockdown with 2 control hairpins and 6 hairpins targeting the PRC2 complex. 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation